PMV Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$68,960,000 over the previous period. Total operating expenses were $80,132,000.
Profit Margin
| 2018 | 0 | -17.53M | |
|---|---|---|---|
| 2019 | 0 | -25.35M | |
| 2020 | 0 | -34.44M | |
| 2021 | 0 | -57.84M | |
| 2022 | 0 | -73.31M | |
| 2023 | 0 | -68.96M |
PMVP Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 1.25M | 650K | 1.28M | 318K | 388K | 0 |
Gross profit | -1.25M | -650K | -1.28M | -318K | -388K | 0 |
Operating exp. | ||||||
Research and development | 55.88M | 51.98M | 36.49M | 23.93M | 20.75M | 13.85M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 80.13M | 77.04M | 58.29M | 34.94M | 26.63M | 18.89M |
Operating income | -80.13M | -77.04M | -58.29M | -34.94M | -26.63M | -18.89M |
Other income (expenses), net | 11.17M | 3.71M | 470K | 508K | 1.29M | 16K |
Income before tax | -68.95M | -73.32M | -57.82M | -34.43M | -25.34M | -17.53M |
Income tax expense | 2K | -9K | 23K | 6K | 8K | 3K |
Net income | -68.96M | -73.31M | -57.84M | -34.44M | -25.35M | -17.53M |
Earnings per share | ||||||
Basic EPS | -1.44 | -1.61 | -1.28 | -0.77 | -0.59 | -0.56 |
Diluted EPS | -1.44 | -1.61 | -1.28 | -0.77 | -0.59 | -0.56 |
| Data source | Data source | Data source | Data source |